Xiqiao Zhou

6PUBLICATIONS
50CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical biochemistry - carbohydratesComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Metabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
CHAIN Cohort: Prospective Multicenter Study of MASLD With Serial Liver Stiffness Assessments in Cardiovascular Care.

|Jun 22, 2026
Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.

|Jan 27, 2026
Potential Targets in Nonalcoholic Steatohepatitis Based on Bioinformatics Analysis and Machine Learning Strategies.

Tiansu Lv, Lingling Zhu, Yuan Han

|Jan 10, 2026
Hepatic HMGCS2-derived β-hydroxybutyrate attenuates hippocampal insulin resistance and neuroinflammation to promote MASLD-induced cognitive function.

Lijuan Nie, Jing Sun, Weilong Xu

|Sep 15, 2025
Nephroprotective Effects of Formononetin in Diabetic Kidney Disease: Mechanistic Insights and Therapeutic Potential.

Siyuan Song, Xiqiao Zhou, Liji Huang

|Jul 04, 2025
Review of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease.

Yifan Lu, Yixuan Xie, Xinyi Yang

Pageof 1

Frequent Collaborators

1 joint publications

Xiao-Dong Zhou

1 joint publications

Ren Cheng-Han Fan

1 joint publications

Jian-Dong Chen

1 joint publications

Qian Tong